Management ChangeJul 9, 2026, 05:17 PM
Biohaven Announces Scientific Leadership Transitions
AI Summary
Biohaven Ltd. announced scientific leadership transitions, effective July 13, 2026. Dr. Bruce Car will transition from Chief Scientific Officer to a new part-time role as Chief Innovation Officer, focusing on external collaborations and the Bexorg partnership, with a 50% salary reduction. Concurrently, Dr. David Pirman has been promoted to Executive Vice President and Head of Discovery, leading the company's internal drug-discovery organization. Warren Volles, General Counsel, was also designated an executive officer.
Key Highlights
- Dr. Bruce Car transitions from Chief Scientific Officer to Chief Innovation Officer.
- Dr. Car's new role is part-time, with a 50% salary reduction.
- Dr. Car will focus on external collaborations, including Bexorg partnership.
- Dr. David Pirman promoted to Executive Vice President and Head of Discovery.
- Dr. Pirman will lead Biohaven's internal drug-discovery organization.
- Warren Volles, General Counsel, designated an executive officer.
Price Impact
More from BHVN